-
Product Insights
Low Carbon Birch Solar PV Plant, UK
Low Carbon Birch Solar PV Plant is proposed to be built in England, United Kingdom. The project is at the permitting stage. Empower your strategies with our Low Carbon Birch Solar PV Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered...
-
Product Insights
Birch Pollen Allergy – Drugs In Development, 2023
Global Markets Direct’s, ‘Birch Pollen Allergy - Drugs In Development, 2023’, provides an overview of the Birch Pollen Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Birch Pollen Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Birch Triterpenes in Radiodermatitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Birch Triterpenes in Radiodermatitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Birch Triterpenes in Radiodermatitis Drug Details: Birch bark extract (Oleogel-S10, Filsuvez, Episalvan)...
-
Product Insights
Lightsource BP Birch solar PV Park
Lightsource BP Birch solar PV Park is a solar PV project located in Ohio, United States. The project is owned and being developed by Lightsource BP Renewable Energy Investments Ltd. The project is at the permitting stage. Empower your strategies with our Lightsource BP Birch solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Allergen For Birch Pollen Allergy in Birch Pollen Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Allergen For Birch Pollen Allergy in Birch Pollen Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Allergen For Birch Pollen Allergy in Birch Pollen...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Allergen For Grass Pollen Allergy in Grass Pollen Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Allergen For Grass Pollen Allergy in Grass Pollen Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allergen For Grass Pollen Allergy in Grass...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Tagtociclib in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tagtociclib in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tagtociclib in Triple-Negative Breast Cancer (TNBC) Drug Details: Tagtociclib (PF-07104091)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Donafenib Tosylate in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Donafenib Tosylate in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Donafenib Tosylate in Esophageal Cancer Drug Details: Donafenib tosylate (Zepsun)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bremzalerbart + Umesolerbart + 5715 in Seasonal Allergic Rhinitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Bremzalerbart + Umesolerbart + 5715 in Seasonal Allergic Rhinitis Drug Details: Bremzalerbart + umesolerbart +...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SHRA-1904 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SHRA-1904 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SHRA-1904 in Solid Tumor Drug Details: SHRA-1904 is under development for...